期刊文献+

降钙素原用于结肠梗阻患者术后脓毒症早期诊断的研究 被引量:1

Effect of procalcitonin on early diagnosis of sepsis in patients with intestinal obstruction
下载PDF
导出
摘要 目的探讨降钙素原用于结肠梗阻患者术后脓毒症早期诊断的价值。方法选择68例结肠梗阻术后患者,记录患者术后24 h血清降钙素原(PCT)、C-反应蛋白(CRP)、白细胞计数(WBC)、血沉(ESR)、中性粒细胞比率(N)、血小板(PLT)及最高体温(T),术后第7d根据脓毒症诊断标准将患者分成脓毒症组、非感染性全身炎症反应综合征组(非感染性SIRS组)比较两组患者术后24h各项临床指标差异。结果脓毒症组患者术后24 h的PCT显著高于非感染性SIRS组(P<0.05),其PCT的ROC曲线下面积(AUC)显著大于CRP、WBC、N和ESR(P<0.05)。结论降钙素原对肠梗阻患者术后脓毒症的发生具有早期诊断价值,其敏感性和特异性高于其他的炎性指标。 Objective To observe the clinical value of procalcitonin on early diagnosis of sepsis in patients with intestinal obstruction .Methods 68 patients with intestinal obstruction after the operation were enrolled in the present study.The change of procalcitonin, CRP, WBC, ESR, GRANR and the highest temperature was observed as early as 24 hours postoperatively .The patients were ultimately divided into two groups according to the diagnostic standard of sepsis , the sepsis group and infective systemic inflammatory response syndrome group(SIRS group)on the 7th day after the operation.Results PCT of the sepsis group was higher evidently than that of the SIRS group , the area under ROC curve of PCT was evidently greater than CRP , WBC and ESR, P〈0.05, which had statistical significance .Conclusions Procalcitonin is a good index of early diagnosis on sepsis in patients with intestinal obstruction postoperatively , its sensitivity and specificity is higher than the other inflammatory indicators .
出处 《齐齐哈尔医学院学报》 2014年第24期3598-3599,共2页 Journal of Qiqihar Medical University
关键词 血降钙素原 结肠梗阻 脓毒症 早期诊断 Procalcitonin Intestinal obstruction Sepsis Early diagnosis
  • 相关文献

参考文献10

二级参考文献42

  • 1葛庆岗,阴赪宏,文艳,吕旌乔,王谊冰.血清降钙素原与多器官功能障碍综合征严重程度相关性的临床研究[J].中国危重病急救医学,2005,17(12):729-731. 被引量:28
  • 2Barrier A, Ferro L, Houry S, et al. Rectal cancer surgery in patients more than 80 years of age. Am J Surg, 2003, 185: 54-57.
  • 3Rigg JR, Jamrozik K, Myles PS, et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomized trial. Lancet, 2002, 359: 1276-1282.
  • 4Aikawa N, Fujishima S, Endo S, et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Che- mother,2005,11 ( 2 ) : 152-159.
  • 5Meynaar IA, Droog W, Batstra M, et al. In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, IL-6, or LBP. Crit Care Res Pract, 2011 (4) :594-645.
  • 6Rey C, Arcos ML, Concha A, et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med, 2007,33 ( 1 ) :477-484.
  • 7Santuz P, Soffiati M, Dorizzi RM, et al. Procalcitonin for the di- agnosis of early-onset neonatal sepsis : a multilevel probabilistic approach. Clin Biochemistry,2008,41 (6) : 1150-1155.
  • 8Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients. Am J Re- spir Crit Care Med,2008,177(4) :498-505.
  • 9Charles PE, Tinel C, Barbar S, et al. Procalcitonin kinetics with- in the first days of sepsis : relationship with the appropriateness of antibiotic therapy and the outcome. Crit Care, 13 (2) :R38.
  • 10第二届肾脏病学术会议组.尿路感染诊断、治疗标准.中华肾脏病杂志,1985,1(4):13-14.

共引文献437

同被引文献8

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部